{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:08Z","timestamp":1786118888564,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s10350-007-0303-9","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T21:07:14Z","timestamp":1188508034000},"page":"1697-1706","source":"Crossref","is-referenced-by-count":69,"title":["Accuracy of Four Fecal Assays in the Diagnosis of Colitis"],"prefix":"10.1097","volume":"50","author":[{"given":"Alain M.","family":"Schoepfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trummler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Seeholzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique H.","family":"Criblez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"303_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.31.1.77","volume":"31","author":"NJ Talley","year":"1990","unstructured":"Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990;31:77\u201381.","journal-title":"Gut"},{"key":"303_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.1997.84256000.x","volume":"11","author":"M Camilleri","year":"1997","unstructured":"Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther 1997;11:3\u201315.","journal-title":"Aliment Pharmacol Ther"},{"key":"303_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/gut.24.4.293","volume":"24","author":"SH Saverymuttu","year":"1983","unstructured":"Saverymuttu SH, Peters AM, Lavender JP, Hodgson HJ, Chadwick VS. 111Indium autologous leucocytes in inflammatory bowel disease. Gut 1983;24:293\u20139.","journal-title":"Gut"},{"key":"303_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(81)90477-3","volume":"2","author":"AW Segal","year":"1981","unstructured":"Segal AW, Ensell J, Munro JM, Sarner M. Indium-111 tagged leucocytes in the diagnosis of inflammatory bowel disease. Lancet 1981;2:230\u20132.","journal-title":"Lancet"},{"key":"303_CR5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0016-5085(83)80015-8","volume":"85","author":"SH Saverymuttu","year":"1983","unstructured":"Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJ, Chadwick VS. Quantitative fecal indium111-labelled leucocyte excretion in the assessment of disease in Crohn\u2019s disease. Gastroenterology 1983;85:1333\u20139.","journal-title":"Gastroenterology"},{"key":"303_CR6","first-page":"927","volume":"91","author":"K Sugi","year":"1996","unstructured":"Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 1996;91:927\u201334.","journal-title":"Am J Gastroenterol"},{"key":"303_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4612-3956-7_17","volume-title":"Lactoferrin","author":"A Naidu","year":"1997","unstructured":"Naidu A, Satyanarayan Arnold. Influence of lactoferrin on host-microbe interactions. In: William Hutchens T, Lonnerdal B, eds. Lactoferrin. New York: Humana Press, 1997:259\u201375."},{"key":"303_CR8","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/JCM.32.10.2629-2630.1994","volume":"32","author":"RL Guerrant","year":"1994","unstructured":"Guerrant RL, Araujo V, Soares E, et al. Measurement of fecal lactoferrin as a marker of fecal leucocytes. J Clin Microbiol 1994;32:2629\u201330.","journal-title":"J Clin Microbiol"},{"key":"303_CR9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","volume":"47","author":"J Tibble","year":"2000","unstructured":"Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn\u2019s disease. Gut 2000;47:506\u201313.","journal-title":"Gut"},{"key":"303_CR10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1572-0241.2003.07458.x","volume":"98","author":"SV Kane","year":"2003","unstructured":"Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309\u201314.","journal-title":"Am J Gastroenterol"},{"key":"303_CR11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0016-5085(79)90384-6","volume":"77","author":"WR Best","year":"1979","unstructured":"Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn\u2019s Disease Activity Index (CDAI). Gastroenterology 1979;77:843\u20136.","journal-title":"Gastroenterology"},{"key":"303_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno M, D\u2019Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD. Gastrointest Endosc 2004;60:505\u201312.","journal-title":"Gastrointest Endosc"},{"key":"303_CR13","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625\u20139.","journal-title":"N Engl J Med"},{"key":"303_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ 1989;298:82\u20136.","journal-title":"BMJ"},{"key":"303_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005176-200107000-00003","volume":"33","author":"SK Bunn","year":"2001","unstructured":"Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;33:14\u201322.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"303_CR16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00042737-200208000-00005","volume":"14","author":"CD Summerton","year":"2002","unstructured":"Summerton CD, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002;14:841\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"303_CR17","first-page":"117","volume":"51","author":"H Silberer","year":"2005","unstructured":"Silberer H, Kuppers B, Mickisch O, et al. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 2005;51:117\u201326.","journal-title":"Clin Lab"},{"key":"303_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365529609006407","volume":"31","author":"TR Meling","year":"1996","unstructured":"Meling TR, Aabakken L, Roseth A, Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996;31:339\u201344.","journal-title":"Scand J Gastroenterol"},{"key":"303_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1708-8305.1994.tb00565.x","volume":"1","author":"EG Scerpella","year":"1994","unstructured":"Scerpella EG, Okhuysen PC, Mathewson JJ, et al. Evaluation of a new latex agglutination test for fecal lactoferrin in travelers\u2019 diarrhea. J Travel Med 1994;1:68\u201371.","journal-title":"J Travel Med"},{"key":"303_CR20","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JCM.34.4.928-932.1996","volume":"34","author":"SW Choi","year":"1996","unstructured":"Choi SW, Park CH, Silva TM, Zaenker EI, Guerrant RL. To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea. J Clin Microbiol 1996;34:928\u201332.","journal-title":"J Clin Microbiol"},{"key":"303_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(85)90219-0","volume":"148","author":"B Shine","year":"1985","unstructured":"Shine B, Berghouse L, Jones JE, Landon J. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta 1985;148:105\u20139.","journal-title":"Clin Chim Acta"},{"key":"303_CR22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00042737-200204000-00013","volume":"14","author":"AP Poullis","year":"2002","unstructured":"Poullis AP, Zar S, Sundaram KK, et al. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol 2002;14:409\u201312.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"303_CR23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/gut.27.7.809","volume":"27","author":"SH Saverymuttu","year":"1986","unstructured":"Saverymuttu SH, Hodgson HJ, Chadwick VS, Pepys MB. Differing acute phase responses in Crohn\u2019s disease and ulcerative colitis. Gut 1986;27:809\u201313.","journal-title":"Gut"},{"key":"303_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/431366","volume":"77","author":"CS Carlson","year":"2005","unstructured":"Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005;77:64\u201377.","journal-title":"Am J Hum Genet"},{"key":"303_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.gene.6363820","volume":"3","author":"AJ Szalai","year":"2002","unstructured":"Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 2002;3:14\u20139.","journal-title":"Genes Immun"},{"key":"303_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/qjmed\/hci069","volume":"98","author":"DR Gaya","year":"2005","unstructured":"Gaya DR, Lyon TD, Duncan A, et al. Faecal calprotectin in the assessment of Crohn\u2019s disease activity. QJM 2005;98:435\u201341.","journal-title":"QJM"},{"key":"303_CR27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1440-1746.2003.03014.x","volume":"18","author":"A Poullis","year":"2003","unstructured":"Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 2003;18:756\u201362.","journal-title":"J Gastroenterol Hepatol"},{"key":"303_CR28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/gast.2002.34755","volume":"123","author":"JA Tibble","year":"2002","unstructured":"Tibble JA, Sigthorsson G, Foster R, et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450\u201360.","journal-title":"Gastroenterology"},{"key":"303_CR29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1136\/gut.2005.070615","volume":"54","author":"P Hanaway","year":"2005","unstructured":"Hanaway P, Roseth A. Inflammatory biomarkers predict relapse in IBD. Gut 2005;54:1346\u20137.","journal-title":"Gut"},{"key":"303_CR30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426\u201331.","journal-title":"Gut"},{"key":"303_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger S, Fagerhol M, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with quiescent inflammatory bowel disease. Gastroenterology 2000;119:15\u201322.","journal-title":"Gastroenterology"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-200750100-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:57:53Z","timestamp":1786035473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003453-200750100-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1007\/s10350-007-0303-9","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}